VLON
Income statement / Annual
Last year (2023), Vallon Pharmaceuticals, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Vallon Pharmaceuticals, Inc.'s net income was -$13.04 M.
See Vallon Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$100,000.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$100,000.00
|
$0.00
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
0
|
1
|
0
|
0
|
Research and Development Expenses |
$3.23 M
|
$1.17 M
|
$5.19 M
|
$3.71 M
|
$1.88 M
|
$3.51 M
|
General & Administrative Expenses |
$8.16 M
|
$5.76 M
|
$4.07 M
|
$1.18 M
|
$1.27 M
|
$800,688.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$8.16 M
|
$5.76 M
|
$4.07 M
|
$1.18 M
|
$1.27 M
|
$800,688.00
|
Other Expenses |
$0.00
|
$0.00
|
$61,000.00
|
$0.00
|
$0.00
|
$0.00
|
Operating Expenses |
$11.39 M
|
$6.93 M
|
$9.26 M
|
$4.89 M
|
$3.15 M
|
$4.31 M
|
Cost And Expenses |
$11.39 M
|
$6.93 M
|
$9.26 M
|
$4.89 M
|
$3.15 M
|
$4.31 M
|
Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Interest Expense |
-$2.08 M
|
$26,000.00
|
$16,000.00
|
$34,000.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$4,000.00
|
$206,000.00
|
$73,000.00
|
$75,000.00
|
$15,735.00
|
$612.00
|
EBITDA |
-$11.39 M |
-$6.93 M |
-$9.26 M |
-$4.71 M |
-$3.03 M |
-$4.31 M |
EBITDA Ratio |
0
|
0
|
0
|
-47.13
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
-47.88
|
0
|
0
|
Total Other Income/Expenses Net |
-$1.65 M
|
-$96,000.00
|
-$44,000.00
|
-$34,000.00
|
-$310,071.00
|
$1,061.00
|
Income Before Tax |
-$13.04 M
|
-$7.02 M
|
-$9.30 M
|
-$4.82 M
|
-$3.46 M
|
-$4.31 M
|
Income Before Tax Ratio |
0
|
0
|
0
|
-48.22
|
0
|
0
|
Income Tax Expense |
$0.00
|
$192,000.00
|
$77,000.00
|
$34,000.00
|
$310,071.00
|
$1,061.00
|
Net Income |
-$13.04 M
|
-$7.22 M
|
-$9.38 M
|
-$4.86 M
|
-$3.77 M
|
-$4.31 M
|
Net Income Ratio |
0
|
0
|
0
|
-48.56
|
0
|
0
|
EPS |
-1.29 |
-0.71 |
-1.43 |
-0.72 |
-0.56 |
-0.74 |
EPS Diluted |
-1.29 |
-0.71 |
-1.43 |
-0.72 |
-0.56 |
-0.74 |
Weighted Average Shares Out |
$10.14 M
|
$10.14 M
|
$6.54 M
|
$6.76 M
|
$6.76 M
|
$5.80 M
|
Weighted Average Shares Out Diluted |
$10.14 M
|
$10.14 M
|
$6.54 M
|
$6.76 M
|
$6.76 M
|
$5.80 M
|
Link |
|
|
|
|
|
|